BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15577851)

  • 21. Eosinophilia in children. Cytochemical and immunological analysis of increased eosinophils.
    Ishii E; Mizuno Y; Hara T; Okamura J; Aoki T; Kanehara Y; Suda M; Takeshita M; Kikuchi M; Ueda K
    Am J Pediatr Hematol Oncol; 1987; 9(4):308-13. PubMed ID: 3439581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Idiopathic eosinophilia].
    Trüeb RM
    Hautarzt; 1997 Mar; 48(3):153-6. PubMed ID: 9182084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.
    Gosset P; Prin L; Capron M; Auriault C; Tonnel AB; Capron A
    Clin Exp Immunol; 1986 Sep; 65(3):654-63. PubMed ID: 3780047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of eosinophil differentiation factor and its relationship to eosinophilia in Mesocestoides corti-infected mice.
    Strath M; Sanderson CJ
    Exp Hematol; 1986 Jan; 14(1):16-20. PubMed ID: 3080321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biological role of interleukin 5.
    Sanderson CJ
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():147-53; discussion 153-4. PubMed ID: 2182734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma membrane antigens on light density and activated human blood eosinophils.
    Tai PC; Bakes DM; Barkans JR; Spry CJ
    Clin Exp Immunol; 1985 May; 60(2):427-36. PubMed ID: 4006306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Idiopathic hypereosinophilic syndrome with predominant digestive manifestations or eosinophilic gastroenteritis? Apropos of 2 cases].
    Levesque H; Elie-Legrand MC; Thorel JM; Touchais O; Gancel A; Hecketsweiller P; Courtois H
    Gastroenterol Clin Biol; 1990; 14(6-7):586-8. PubMed ID: 2397867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity.
    Rothenberg ME; Petersen J; Stevens RL; Silberstein DS; McKenzie DT; Austen KF; Owen WF
    J Immunol; 1989 Oct; 143(7):2311-6. PubMed ID: 2506282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prolonged course of an idiopathic hypereosinophilic syndrome with transition to eosinophilic gastroenteritis].
    Bauer S; Schaub N; Kummer H; Wegmann W
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1976-81. PubMed ID: 7973531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wells' syndrome associated with idiopathic hypereosinophilic syndrome.
    Bogenrieder T; Griese DP; Schiffner R; Büttner R; Riegger GA; Hohenleutner U; Landthaler M
    Br J Dermatol; 1997 Dec; 137(6):978-82. PubMed ID: 9470919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophil kinetics in the hypereosinophilic syndrome.
    Dale DC; Hubert RT; Fauci A
    J Lab Clin Med; 1976 Mar; 87(3):487-95. PubMed ID: 1249478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Flow cytometry study on purification of human eosinophils and cell function].
    Takahashi K; Soda R; Okada C; Nakatou H; Sunami K; Takeda K; Tanimoto Y; Katagi Y; Kawada I; Kimura G
    Arerugi; 1993 Apr; 42(4):541-8. PubMed ID: 8323452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign idiopathic hypereosinophilia: a feeble masquerader or a smouldering form of the hypereosinophilic syndrome?
    Confalonieri M; Tacconi F; De Amici M; Maccario R; Porta C; Gioglio L; Bobbio-Pallavicini E
    Haematologica; 1995; 80(1):50-3. PubMed ID: 7758993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of serum and cellular interleukin-5 in posttreatment eosinophilia of patients with lymphatic filariasis.
    Limaye AP; Ottesen EA; Kumaraswami V; Abrams JS; Regunathan J; Vijayasekaran V; Jayaraman K; Nutman TB
    J Infect Dis; 1993 Jun; 167(6):1396-400. PubMed ID: 8501330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypereosinophilic syndrome.
    Purdie GH; Kotasek D; Rischbieth RH
    Clin Exp Neurol; 1983; 19():60-6. PubMed ID: 6096051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypereosinophilia during 2-chlorodeoxyadenosine treatment for hairy cell leukaemia.
    Rutella S; Sica S; Rumi C; Martucci R; Etuk B; De Stefano V; Testa U; Leone G; Peschle C
    Br J Haematol; 1996 Feb; 92(2):426-8. PubMed ID: 8603011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of fifteen patients with the hypereosinophilic syndrome.
    Spry CJ; Davies J; Tai PC; Olsen EG; Oakley CM; Goodwin JF
    Q J Med; 1983; 52(205):1-22. PubMed ID: 6878618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.
    Owen WF; Petersen J; Sheff DM; Folkerth RD; Anderson RJ; Corson JM; Sheffer AL; Austen KF
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8647-51. PubMed ID: 2236076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Episodic angioedema with eosinophilia].
    Tomoe S; Iwamoto I
    Nihon Rinsho; 1993 Mar; 51(3):795-9. PubMed ID: 8492460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome.
    Owen WF; Rothenberg ME; Petersen J; Weller PF; Silberstein D; Sheffer AL; Stevens RL; Soberman RJ; Austen KF
    J Exp Med; 1989 Jul; 170(1):343-8. PubMed ID: 2787385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.